Vicor Other Income (Expense) decreased by 0.7% to $3.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $3.13M to $3.52M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 80.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $373.00K | $394.00K | $204.00K | $162.00K | $84.00K | -$568.00K | $1.81M | $1.95M | $1.78M | $1.92M | $3.24M | $2.72M | $2.81M | $3.71M | $2.55M | $3.13M | $3.66M | $2.41M | $3.55M | $3.52M |
| QoQ Change | — | +5.6% | -48.2% | -20.6% | -48.1% | -776.2% | +418.3% | +7.9% | -8.9% | +7.9% | +69.2% | -16.0% | +3.0% | +32.3% | -31.2% | +22.8% | +16.7% | -34.2% | +47.3% | -0.7% |
| YoY Change | — | — | — | — | -77.5% | -244.2% | +786.3% | >999% | >999% | +437.5% | +79.4% | +39.7% | +58.1% | +93.7% | -21.3% | +15.1% | +30.3% | -35.2% | +38.9% | +12.3% |